HCA Healthcare, Inc.
HCA Healthcare Medical - Care Facilities NYSE
$432.50
$-41.53 (-8.76%)
Open: $430.00 | High: $451.57 | Low: $422.23 | Prev Close: Prev Close: $474.03
Market Cap: $96.69B
Volume: 3.2M | Avg: 1.1M
Last updated: April 24, 2026 at 08:02 PMInvestment Rating
Strong Sell
Overall Score: 20/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 565
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 15.26 |
| P/B Ratio | 0.00 |
| P/S Ratio | 1.28 |
| EPS | $28.35 |
| Beta | 1.37 |
| Shares Outstanding | 223.57M |
| 52-Week High | $556.52 |
| 52-Week Low | $321.39 |
| SMA 50 | $508.70 |
| SMA 200 | $455.53 |
| Dividend Yield | 0.68% |
| Annual Dividend | $2.94 |
| Next Earnings | July 23, 2026 12:00 PM ET |
Financial Ratios
| Gross Margin | 41.5% |
| Operating Margin | 15.8% |
| Net Margin | 9.0% |
| ROE | -172.2% |
| ROA | 7.2% |
| Debt/Equity | 0.00 |
| Current Ratio | 0.80 |
| Quick Ratio | 0.70 |
Balance Sheet
| Total Assets | $60.72B |
| Total Liabilities | $63.49B |
| Total Equity | $-6,027,000,000 |
|
|
|
| Cash | $1.04B |
| Total Debt | $50.20B |
| Net Debt | $49.16B |
Income Statement
| Revenue | $75.60B |
| Gross Profit | $31.37B |
| Operating Income | $11.96B |
| Net Income | $6.78B |
|
|
|
| EBITDA | $15.60B |
| Revenue/Share | $327.68 |
Cash Flow
| Operating CF | $12.64B |
| CapEx | $4.94B |
| Free Cash Flow | $7.69B |
|
|
|
| Book Value/Share | $409.70 |
| Tangible Book/Share | $364.18 |
| Equity/Share | $0.00 |
Technical Indicators
| RSI (14) | 33.01 Neutral |
| MACD |
-9.90
Signal: -6.63
|
| Volatility | 32.37% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | +14.28% |
| Sharpe Ratio | 0.61 Fair |
| Volatility (Ann.) | 30.81% Moderate |
| HCA (1Y) | +14.28% |
| S&P 500 (1Y) | +14.41% |
| Alpha (Excess Return) | -0.12% |
Sector Comparison (Healthcare)
| Metric | HCA | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 15.26 | 26.46 | 18% |
| ROE (%) | -172.23% | -6.38% | 6% |
| Net Margin (%) | 8.97% | 9.45% | 38% |
| Stock Score | 565 | 548.0 | 54% |
| 1Y Return (%) | +14.28 % | +4.95 % | 67% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCA | $432.50 | $470.28 | $478.44 | $487.14 | $508.23 | $456.21 | 33.01 | -9.90 | 32.37% | 878904 | Strong Short | Bearish Stack |
Candlestick Patterns
There wasn't any recognizable pattern for the HCA stock
News Sentiment
| Ticker | Headline | Sentiment | Source | URL |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. $HCA Shares Sold by Calamos Advisors LLC | Neutral | defenseworld.net | Read More |
| HCA | HCA Healthcare, Inc. (NYSE:HCA) Given Consensus Rating of “Moderate Buy” by Analysts | Neutral | defenseworld.net | Read More |
| HCA | HCA Healthcare Inc (HCA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges | Positive | gurufocus.com | Read More |
| HCA | HCA Healthcare: Policy Pressures May Be Limiting Admissions (Upgrade) | Neutral | seekingalpha.com | Read More |
| HCA | HCA Healthcare, Inc. (HCA) Q1 2026 Earnings Call Transcript | Neutral | seekingalpha.com | Read More |
Recent Insider Trading
No recent insider trading data available for HCA
Company Information
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
| CEO | Samuel N. Hazen |
| Employees | 320000 |
| Country | US |
| IPO Date | 2011-03-10 |
| Exchange | NYSE |
| Website | https://www.hcahealthcare.com |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
Similar Stocks (Healthcare - Medical - Care Facilities)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category